J.W. Cole Advisors Inc. Grows Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

J.W. Cole Advisors Inc. increased its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 212.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 11,818 shares of the company's stock after acquiring an additional 8,033 shares during the quarter. J.W. Cole Advisors Inc.'s holdings in GE HealthCare Technologies were worth $954,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of GEHC. CoreFirst Bank & Trust acquired a new stake in shares of GE HealthCare Technologies in the 4th quarter valued at $25,000. Bogart Wealth LLC boosted its stake in shares of GE HealthCare Technologies by 260.0% in the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company's stock valued at $28,000 after purchasing an additional 247 shares in the last quarter. Stonebridge Financial Group LLC boosted its stake in shares of GE HealthCare Technologies by 165.7% in the 1st quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock valued at $29,000 after purchasing an additional 222 shares in the last quarter. LGT Financial Advisors LLC boosted its stake in shares of GE HealthCare Technologies by 46.2% in the 4th quarter. LGT Financial Advisors LLC now owns 389 shares of the company's stock valued at $30,000 after purchasing an additional 123 shares in the last quarter. Finally, Accredited Wealth Management LLC acquired a new stake in shares of GE HealthCare Technologies in the 4th quarter valued at $30,000. Institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock traded up $0.95 during trading hours on Monday, hitting $78.56. 818,462 shares of the company's stock traded hands, compared to its average volume of 3,994,906. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80. The stock has a market capitalization of $35.97 billion, a price-to-earnings ratio of 16.54, a PEG ratio of 2.62 and a beta of 1.14. The company has a fifty day simple moving average of $73.28 and a 200-day simple moving average of $76.97. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.98 and a quick ratio of 0.76.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its earnings results on Wednesday, April 30th. The company reported $1.01 EPS for the quarter, topping the consensus estimate of $0.91 by $0.10. The business had revenue of $4.78 billion during the quarter, compared to the consensus estimate of $4.66 billion. GE HealthCare Technologies had a return on equity of 24.95% and a net margin of 11.02%. The firm's revenue was up 2.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.90 EPS. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies announced that its Board of Directors has approved a share repurchase program on Wednesday, April 30th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the company to buy up to 3.1% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company's leadership believes its stock is undervalued.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Investors of record on Friday, July 25th will be paid a $0.035 dividend. The ex-dividend date is Friday, July 25th. This represents a $0.14 annualized dividend and a yield of 0.18%. GE HealthCare Technologies's payout ratio is 2.95%.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on GEHC shares. Piper Sandler cut their target price on shares of GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 23rd. Evercore ISI cut their target price on shares of GE HealthCare Technologies from $96.00 to $85.00 and set an "outperform" rating on the stock in a research report on Thursday, May 1st. The Goldman Sachs Group cut their price target on shares of GE HealthCare Technologies from $94.00 to $82.00 and set a "buy" rating on the stock in a research report on Thursday, May 1st. UBS Group upgraded shares of GE HealthCare Technologies from a "sell" rating to a "neutral" rating and cut their price target for the company from $74.00 to $73.00 in a research report on Monday, May 5th. Finally, Wells Fargo & Company cut their price target on shares of GE HealthCare Technologies from $103.00 to $89.00 and set an "overweight" rating on the stock in a research report on Thursday, May 1st. Three equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $88.55.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.